title: Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro.
abstract: Porphycenes are chemically pure photosensitizers for topical and systemic photodynamic therapy (PDT). Fast cellular uptake of 9-acetoxy-2,7,12,17-tetrakis-(sB-methoxyethyl)porphycene (ATMPn) has been shown previously.HaCaT human keratinocytes were incubated with ATMPn (1 nmol l(-1) to 1 micromol l(-1) in DMSO or DOPC liposomes). After 1 h, cells were irradiated with different light doses (0, 24, 48J cm(-2)) using an incoherent light source (580-740 nm, 40 mW cm(-2)). Cytotoxic effects were determined by assessing the mitochondrial activity using the MTT assay 24 h following irradiation.Cytotoxic effects were dependent on ATMPn concentration and light dose. Using 20 nmol 1(-1), a 50% decrease of mitochondrial activity (EC(50)) after irradiation with 24 J cm(-2) was achieved. Lowering the ATMPn concentration (10nmol 1(-1)) and increasing the light dose (48 J cm(-2)) yielded the same effect (EC(50)). Maximal decrease of mitochondrial activity (90%) was achieved using ATMPn concentrations of 50-100 nmol l(-1) and a light dose of 24 J cm(-2) or 25 nmol l(-1) ATMPn and 48 Jcm(-2).There was no difference regarding the dose-dependent cytotoxic effects using either ATMPn in DMSO or DOPC liposomes. In the control group (incubation with 1 nmol 1(-1) to 1micromol 1(-1) ATMPn, no irradiation), dark toxicity was not observed.Cell photosensitization with ATMPn was very efficient in vitro yielding the maximal cytotoxic effect at very low ATMPn concentrations as compared to other photosensitizers. Since ATMPn in DMSO and DOPC liposomes revealed the same cytotoxic effects without dark toxicity, theDMSO formulation, which is much easier to prepare, will be preferred in future studies.
authors.affiliation: Department of Dermatology, University of Regensburg, D93042, Regensburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Karrer
authors.forename: R M
authors.initials: RM
authors.lastname: Szeimies
authors.forename: A
authors.initials: A
authors.lastname: Ebert
authors.forename: S
authors.initials: S
authors.lastname: Fickweiler
authors.forename: C
authors.initials: C
authors.lastname: Abels
authors.forename: W
authors.initials: W
authors.lastname: Bäumler
authors.forename: M
authors.initials: M
authors.lastname: Landthaler
references.citation: J Cell Biol. 1988 Mar;106(3):761-71
references.pmid: 2450098
references.citation: J Photochem Photobiol B. 1996 Jun;34(1):67-72
references.pmid: 8765661
references.citation: Lasers Surg Med. 1988;8(3):294-300
references.pmid: 2969070
references.citation: Int J Cancer. 1996 Jan 17;65(2):246-8
references.pmid: 8567124
references.citation: Br J Cancer. 1994 Jul;70(1):21-8
references.pmid: 8018536
references.citation: Cancer Lett. 1988 Aug 30;41(3):315-21
references.pmid: 3409210
references.citation: Cancer Res. 1989 Apr 1;49(7):1718-21
references.pmid: 2522346
references.citation: Arch Dermatol Res. 1997 Feb;289(3):132-7
references.pmid: 9128760
references.citation: J Natl Cancer Inst. 1993 Mar 17;85(6):443-56
references.pmid: 8445672
references.citation: Cancer Res. 1992 Jun 15;52(12):3443-8
references.pmid: 1534512
references.citation: J Med Chem. 1994 Aug 19;37(17):2797-807
references.pmid: 8064807
references.citation: Arch Dermatol. 1992 Dec;128(12):1631-6
references.pmid: 1456759
references.citation: Radiat Res. 1989 Oct;120(1):1-18
references.pmid: 2678224
references.citation: J Immunol Methods. 1990 Jun 12;130(1):149-51
references.pmid: 2358686
references.citation: J Photochem Photobiol B. 1997 Oct;40(3):305-12
references.pmid: 9372621
references.citation: Acta Derm Venereol. 1994 Mar;74(2):117-9
references.pmid: 7911616
references.citation: Photochem Photobiol. 1986 Nov;44(5):555-9
references.pmid: 3809253
references.citation: J Invest Dermatol. 1995 Nov;105(5):672-7
references.pmid: 7594642